Douglas C. Harnish is an accomplished inventor based in Warrington, PA (US). He has made significant contributions to the field of medical research, particularly in the area of therapeutics related to heart disease and myocardial ischemia-reperfusion injury. With a total of 3 patents to his name, Harnish's work has the potential to impact patient care and treatment options.

Latest Patents

Harnish's latest patents include an assay to identify estrogen receptor-dependent ligands that regulate the hepatic lipase promoter. This invention relates to a system and method for testing compounds that can regulate the hepatic lipase (HL) promoter. The identification of estrogen receptor ligands with this activity is crucial, as compounds that inhibit HL promoter activity can lead to the development of therapeutics aimed at preventing heart disease. Another notable patent is a method of treating myocardial ischemia-reperfusion injury using NF-kB inhibitors. This invention outlines a treatment or prevention method for myocardial ischemia-reperfusion injury by administering a therapeutically effective amount of a ligand that interacts with estrogen receptors, specifically ER-α and ER-β, while minimizing creatine kinase stimulation.

Career Highlights

Douglas C. Harnish is currently associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on innovative research that addresses critical health issues. Harnish's dedication to advancing medical science is evident in his patent portfolio and ongoing research efforts.

Collaborations

Harnish has collaborated with notable colleagues, including Sotirios K. Karathanasis and Chu-Lai Hsiao. These collaborations have likely contributed to the development of his innovative patents and research initiatives.

Conclusion

Douglas C. Harnish is a notable inventor whose work in the medical field has the potential to improve therapeutic approaches for heart disease and related conditions. His patents reflect a commitment to innovation and a desire to enhance patient care through scientific advancements.